graph Evidence gap map comparisons
atezolizumab based treatment
atezolizumab plus bevacizumab plus carboplatin plus paclitaxel
non squamous cell - mNSCLC - L1
non squamous - mNSCLC - L1 - all population 3   
non squamous - mNSCLC - L1 - PDL1 positive
non squamous - mNSCLC - L1 - Wild Type (WT) 6    
Comparator:  vs bevacizumab plus carboplatin and paclitaxel; 
Risk of bias:  low;   some concerns;   high;  NA;